WuXi CEO Seeks To Take Firm Private | Chemical & Engineering News
Volume 93 Issue 18 | p. 17 | Concentrates
Issue Date: May 4, 2015

WuXi CEO Seeks To Take Firm Private

Department: Business
Keywords: contract research, biomanufacturing

WuXi Pharmatech, a Chinese provider of drug R&D and manufacturing services, has received a takeover offer worth more than $3 billion from founder and CEO Ge Li and Ally Bridge Group Capital Partners. WuXi will form a committee to consider it. Li founded WuXi in 2000, expanding it into a research outsourcing behemoth with more than 8,000 employees and sales last year of $674 million. Last week the firm announced that it is building the world’s largest disposable-bioreactor-based mammalian cell culture facility in the city of Wuxi, China.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment